VIVET THERAPEUTICS Trademark

Trademark Overview


On Friday, February 3, 2017, a trademark application was filed for VIVET THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the VIVET THERAPEUTICS trademark a serial number of 79222595. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, April 29, 2025. This trademark is owned by VIVET THERAPEUTICS. The VIVET THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical [ and veterinary ] products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders [ ; immunosuppression pharmaceutical and veterinary products; sanitary preparations for medical purposes; Biological preparations for clinical medical use intended for gene therapy and cell therapy; Clinical medical reagents used for gene therapy, genetic testing and diagnosis; Cellular preparations for medical, pharmaceutical or veterinary use for gene therapy and cell therapy; Gene therapy products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired i...
vivet therapeutics

General Information


Serial Number79222595
Word MarkVIVET THERAPEUTICS
Filing DateFriday, February 3, 2017
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, April 29, 2025
Registration Number5592503
Registration DateTuesday, October 30, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2018

Trademark Statements


Goods and ServicesPharmaceutical [ and veterinary ] products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders [ ; immunosuppression pharmaceutical and veterinary products; sanitary preparations for medical purposes; Biological preparations for clinical medical use intended for gene therapy and cell therapy; Clinical medical reagents used for gene therapy, genetic testing and diagnosis; Cellular preparations for medical, pharmaceutical or veterinary use for gene therapy and cell therapy; Gene therapy products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders; Immunosuppression gene therapy products ]
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVIVET THERAPEUTICS
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party NameVIVET THERAPEUTICS
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party NameVIVET THERAPEUTICS
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Friday, December 15, 2017ASSIGNED TO EXAMINER
Thursday, December 7, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 12, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, December 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 15, 2017NON-FINAL ACTION WRITTEN
Saturday, December 16, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 19, 2017APPLICATION FILING RECEIPT MAILED
Monday, January 8, 2018REFUSAL PROCESSED BY MPU
Monday, January 8, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, January 27, 2018REFUSAL PROCESSED BY IB
Friday, July 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 14, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 30, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, February 8, 2019FINAL DISPOSITION PROCESSED
Wednesday, July 25, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, August 11, 2018NOTIFICATION PROCESSED BY IB
Tuesday, August 14, 2018PUBLISHED FOR OPPOSITION
Thursday, October 18, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, October 30, 2018REGISTERED-PRINCIPAL REGISTER
Friday, February 8, 2019FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 30, 2024TEAS SECTION 71 RECEIVED
Monday, April 7, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 17, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 28, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 1, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 26, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, November 14, 2019NEW REPRESENTATIVE AT IB RECEIVED
Monday, October 30, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, August 16, 2024NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, April 29, 2025REGISTERED-SEC.71 ACCEPTED
Tuesday, April 29, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED